It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

Longhorn Vaccines & Diagnostics ("Longhorn"), a One Health company developing antibodies and diagnostic tools for global ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

A recent study found that markers of platelet activity are increased in plasma of patients with pulmonary tuberculosis and these are then normalized with antimycobacterial treatment. The researchers ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Tuberculosis (TB) continues to be one of the world's leading causes of infectious disease-related illness and death. Despite ...

Single-cell RNA sequencing identified distinct immune profiles in extrapulmonary TB, linking interferon–IL-1 signaling to ...

A groundbreaking study from the University of Cape Town reveals that most tuberculosis cases are asymptomatic at screening, ...

Tuberculosis cases continue to fall in the United States, but some immigrants have disturbingly high rates of the disease, according to a study released Tuesday that called for more aggressive action.

San Antonio, Texas (February 15, 2020) - Researchers at the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) may have found a new pathway to ...